{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T18:52:43Z","timestamp":1726080763903},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patients with HIV have a higher prevalence of thrombocytopenia than those without HIV infection, increasing their risk of substantial perioperative blood loss (PBL) during total hip arthroplasty (THA). This study aimed to evaluate PBL risk factors in HIV-infected patients undergoing THA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Eighteen HIV+ patients (21 hip joints) and 33 HIV\u2212 patients (36 joints) undergoing THA were enrolled in this study. PBL was calculated using the Gross equation, which comprises total blood loss (TBL), dominant blood loss (DBL), and hidden blood loss (HBL). Risk factors for post-THA PBL in both patient populations was evaluated using multivariable linear regression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>At baseline, the HIV+ patients were younger, more likely to be male and to have elevated hemoglobin and albumin levels, and lower erythrocyte sedimentation rates than HIV\u2212 patients. There were no differences in the T-lymphocyte subsets or coagulation function between the two groups. Age and albumin level were identified as potential HBL risk factors after THA, and albumin level was associated with higher TBL. The unadjusted linear regression analysis showed that the HBL and TBL were significantly higher in HIV+ patients than in HIV\u2212 patients. However, after adjusting for other factors, no differences in DBL, HBL, or TBL were observed between HIV\u2212 and HIV+ patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>PBL was similar in both groups undergoing THA, regardless of their HIV-infection status. THA surgery is a safe and effective procedure in HIV+ patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13018-022-03055-y","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T11:03:11Z","timestamp":1646823791000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["HIV infection is not associated with perioperative blood loss in patients undergoing total hip arthroplasty"],"prefix":"10.1186","volume":"17","author":[{"given":"Qifeng","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaorui","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoneng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maoye","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianjia","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,9]]},"reference":[{"issue":"12","key":"3055_CR1","doi-asserted-by":"publisher","first-page":"e831","DOI":"10.1016\/S2352-3018(19)30196-1","volume":"6","author":"GBD 2017 HIV collaborators","year":"2019","unstructured":"GBD 2017 HIV collaborators. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980\u20132017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. Lancet HIV. 2019;6(12):e831\u201359.","journal-title":"Lancet HIV"},{"issue":"Suppl 1","key":"3055_CR2","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1086\/313843","volume":"30","author":"JE Kaplan","year":"2000","unstructured":"Kaplan JE, Hanson D, Dworkin MS, Frederick T, Bertolli J, Lindegren ML, et al. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis. 2000;30(Suppl 1):S5-14.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"3055_CR3","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1097\/00126334-200202011-00005","volume":"29","author":"WG Powderly","year":"2002","unstructured":"Powderly WG. Long-term exposure to lifelong therapies. J Acquir Immune Defic Syndr. 2002;29(Suppl 1):S28-40.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"3055_CR4","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/00002030-200202150-00021","volume":"16","author":"F Guti\u00e9rrez","year":"2002","unstructured":"Guti\u00e9rrez F, Padilla S, Ortega E, Garc\u00eda JA, Flores J, Galera C, et al. Avascular necrosis of the bone in HIV-infected patients: incidence and associated factors. AIDS. 2002;16(3):481\u20133.","journal-title":"AIDS"},{"issue":"6","key":"3055_CR5","first-page":"451","volume":"66","author":"BP Goorney","year":"1990","unstructured":"Goorney BP, Lacey H, Thurairajasingam S, Brown JD. Avascular necrosis of the hip in a man with HIV infection. Genitourin Med. 1990;66(6):451\u20132.","journal-title":"Genitourin Med"},{"issue":"9","key":"3055_CR6","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1097\/00002030-199906180-00025","volume":"13","author":"D Meyer","year":"1999","unstructured":"Meyer D, Behrens G, Schmidt RE, Stoll M. Osteonecrosis of the femoral head in patients receiving HIV protease inhibitors. AIDS. 1999;13(9):1147\u20138.","journal-title":"AIDS"},{"issue":"1","key":"3055_CR7","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1302\/0301-620X.75B1.8421018","volume":"75","author":"X Chevalier","year":"1993","unstructured":"Chevalier X, Larget-Piet B, Hernigou P, Gherardi R. Avascular necrosis of the femoral head in HIV-infected patients. J Bone Joint Surg Br. 1993;75(1):160.","journal-title":"J Bone Joint Surg Br"},{"issue":"3","key":"3055_CR8","first-page":"601","volume":"24","author":"J Rademaker","year":"1997","unstructured":"Rademaker J, Dobro JS, Solomon G. Osteonecrosis and human immunodeficiency virus infection. J Rheumatol. 1997;24(3):601\u20134.","journal-title":"J Rheumatol"},{"issue":"5","key":"3055_CR9","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S0899-7071(99)00151-5","volume":"23","author":"MF Blacksin","year":"1999","unstructured":"Blacksin MF, Kloser PC, Simon J. Avascular necrosis of bone in human immunodeficiency virus infected patients. Clin Imaging. 1999;23(5):314\u20138.","journal-title":"Clin Imaging"},{"key":"3055_CR10","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1086\/511683","volume":"44","author":"CG Morse","year":"2007","unstructured":"Morse CG, Mican JM, Jones EC, Joe GO, Rick ME, Formentini E, et al. The incidence and natural history of osteonecrosis in HIV-infected adults. Clin Infect Dis. 2007;44:739\u201348.","journal-title":"Clin Infect Dis"},{"key":"3055_CR11","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1097\/01.aids.0000238409.90571.02","volume":"20","author":"M Mary-Krause","year":"2006","unstructured":"Mary-Krause M, Billaud E, Poizot-Martin I, Simon A, Dhiver C, Dupont C, et al. Risk factors for osteonecrosis in HIV-infected patients: impact of treatment with combination antiretroviral therapy. AIDS. 2006;20:1627\u201335.","journal-title":"AIDS"},{"key":"3055_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.7326\/0003-4819-137-1-200207020-00008","volume":"137","author":"KD Miller","year":"2002","unstructured":"Miller KD, Masur H, Jones EC, Joe GO, Rick ME, Kelly GG, et al. High prevalence of osteonecrosis of the femoral head in HIV-infected adults. Ann Intern Med. 2002;137:17\u201325.","journal-title":"Ann Intern Med"},{"issue":"2","key":"3055_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1093\/inthealth\/ihaa036","volume":"13","author":"A Marchionatti","year":"2021","unstructured":"Marchionatti A, Parisi MM. Anemia and thrombocytopenia in people living with HIV\/AIDS: a narrative literature review. Int Health. 2021;13(2):98\u2013109.","journal-title":"Int Health"},{"key":"3055_CR14","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3389\/fimmu.2014.00649","volume":"5","author":"A Assinger","year":"2014","unstructured":"Assinger A. Platelets and infection\u2014an emerging role of platelets in viral infection. Front Immunol. 2014;5:649.","journal-title":"Front Immunol"},{"issue":"1","key":"3055_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000313782","volume":"124","author":"AM Passos","year":"2010","unstructured":"Passos AM, Treitinger A, Spada C. An overview of the mechanisms of HIV-related thrombocytopenia. Acta Haematol. 2010;124(1):13\u20138.","journal-title":"Acta Haematol"},{"issue":"3","key":"3055_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/00000542-198303000-00016","volume":"58","author":"JB Gross","year":"1983","unstructured":"Gross JB. Estimating allowable blood loss: corrected for dilution. Anesthesiology. 1983;58(3):277\u201380.","journal-title":"Anesthesiology"},{"issue":"4","key":"3055_CR17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0261-5614(03)00098-0","volume":"22","author":"J Kondrup","year":"2003","unstructured":"Kondrup J, Allison SP, Elia M, Vellas B, Plauth M, Educational and Clinical Practice Committee, European Society of Parenteral and Enteral Nutrition (ESPEN). ESPEN guidelines for nutrition screening 2002. Clin Nutr. 2003;22(4):415\u201321.","journal-title":"Clin Nutr"},{"issue":"10158","key":"3055_CR18","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/S0140-6736(18)31777-X","volume":"392","author":"RJ Ferguson","year":"2018","unstructured":"Ferguson RJ, Palmer AJ, Taylor A, Porter ML, Malchau H, Glyn-Jones S. Hip replacement. Lancet. 2018;392(10158):1662\u201371.","journal-title":"Lancet"},{"issue":"1","key":"3055_CR19","first-page":"1","volume":"17","author":"GT Allison","year":"2003","unstructured":"Allison GT, Bostrom MP, Glesby MJ. Osteonecrosis in HIV disease: epidemiology, etiologies, and clinical management. AIDS. 2003;17(1):1\u20139.","journal-title":"AIDS"},{"issue":"1","key":"3055_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/00042560-200109010-00017","volume":"28","author":"JC Keruly","year":"2001","unstructured":"Keruly JC, Chaisson RE, Moore RD. Increasing incidence of avascular necrosis of the hip in HIV-infected patients. J Acquir Immune Defic Syndr. 2001;28(1):101\u20132.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3055_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12865-015-0092-1","volume":"16","author":"A Chabert","year":"2015","unstructured":"Chabert A, Hamzeh-Cognasse H, Pozzetto B, Cognasse F, Schattner M, Gomez RM, et al. Human platelets and their capacity of binding viruses: meaning and challenges. BMC Immunol. 2015;16:26.","journal-title":"BMC Immunol"},{"issue":"2","key":"3055_CR22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s12288-011-0124-9","volume":"28","author":"FG Nascimento","year":"2012","unstructured":"Nascimento FG, Tanaka PY. Thrombocytopenia in HIV-infected patients. Indian J Hematol Blood Transfus. 2012;28(2):109\u201311.","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"2","key":"3055_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.5501\/wjv.v2.i2.91","volume":"2","author":"D Gibellini","year":"2013","unstructured":"Gibellini D, Cl\u00f2 A, Morini S, Miserocchi A, Ponti C, Re MC. Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages. World J Virol. 2013;2(2):91\u2013101.","journal-title":"World J Virol"},{"issue":"1","key":"3055_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/2052-1839-14-8","volume":"14","author":"B Enawgaw","year":"2014","unstructured":"Enawgaw B, Alem M, Addis Z, Melku M. Determination of hematological and immunological parameters among HIV positive patients taking highly active antiretroviral treatment and treatment na\u00efve in the antiretroviral therapy clinic of Gondar University Hospital, Gondar, Northwest Ethiopia: a comparative cross-sectional study. BMC Hematol. 2014;14(1):8.","journal-title":"BMC Hematol"},{"key":"3055_CR25","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1186\/1471-2334-14-496","volume":"14","author":"R Kyeyune","year":"2014","unstructured":"Kyeyune R, Saathoff E, Ezeamama AE, L\u00f6scher T, Fawzi W, Guwatudde D. Prevalence and correlates of cytopenias in HIV-infected adults initiating highly active antiretroviral therapy in Uganda. BMC Infect Dis. 2014;14:496.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"3055_CR26","first-page":"466","volume":"24","author":"Y Cong","year":"2011","unstructured":"Cong Y, Zhao JN, Bao NR, Zeng XF, Guo T, Cheng XH, et al. Prognostic significance of hidden blood loss in total hip arthroplasty (THA). Zhongguo Gu Shang. 2011;24(6):466\u20138.","journal-title":"Zhongguo Gu Shang"},{"issue":"12","key":"3055_CR27","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1016\/j.arth.2015.06.005","volume":"30","author":"F Gao","year":"2015","unstructured":"Gao F, Sun W, Guo W, Li Z, Wang W, Cheng L. Topical application of tranexamic acid plus diluted epinephrine reduces postoperative hidden blood loss in total hip arthroplasty. J Arthroplasty. 2015;30(12):2196\u2013200.","journal-title":"J Arthroplasty"},{"issue":"5","key":"3055_CR28","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/MBC.0000000000000743","volume":"29","author":"Y Wu","year":"2018","unstructured":"Wu Y, Zeng Y, Bao X, Xiong H, Fan X, Shen B. Application of tranexamic acid and diluted epinephrine in primary total hip arthroplasty. Blood Coagul Fibrinolysis. 2018;29(5):451\u20137.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"3","key":"3055_CR29","doi-asserted-by":"publisher","first-page":"140","DOI":"10.5371\/hp.2021.33.3.140","volume":"33","author":"MM Sylla","year":"2021","unstructured":"Sylla MM, Gruffi L, Roth ES, Rosato FE, Wong CHJ, Razi AE. How does iron deficiency anemia impact outcomes following revision total hip arthroplasty. Hip Pelvis. 2021;33(3):140\u20136.","journal-title":"Hip Pelvis"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-022-03055-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-022-03055-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-022-03055-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T11:40:38Z","timestamp":1646826038000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-022-03055-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,9]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3055"],"URL":"https:\/\/doi.org\/10.1186\/s13018-022-03055-y","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,9]]},"assertion":[{"value":"18 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethical Committee of the Shenzhen Third People's Hospital; written informed consent was obtained from each participating patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors are agreeing to publish this article to this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"155"}}